Synonyms: (1R,4S)-trans-norsertraline | SEP-225,289 | SEP-225289
Compound class:
Synthetic organic
Comment: Dasotraline is a triple reuptake inhibitor [1,3]. Such compounds are also known as serotonin-norepinephrine-dopamine reuptake inhibitors, or SNDRIs. Structurally, dasotraline is a stereoisomer of an active metabolite of sertraline, a selective serotonin reuptake inhibitor (SSRI) antidepressant.
|
|
Bioactivity Comments |
To date, IC50 values for the inhibition of monoamine transporters by dasotraline has only been reported in a meeting abstract (Schreiber R, Lew R, Hardy L, Cremers T, et al (2009) Pharmacological characterization of the triple monoamine transporter inhibitor SEP-225289. Society for Neuroscience (Abstract no. 549.8/X2)). IC50s for inhibiton of rat SERT, NET and DAT are 11, 6 and 4nM respectively. In vivo drug occupancy has been evaluated as a more accurate indication of a drug's transporter binding profile. PET results show that dasotraline ocupies ~85% of dopamine transporter sites, whereas serotonin transporter occupancy was too low to calculate accurately [2]. This result is despite in vitro binding to each transporter being similar. |